Search research articles
Contact Us
Filters
Showing results (741-750 of 841) with videos related to
Page
of 85
Sort By:
Journal of Cutaneous Pathology
|
March 8, 2018
Tumor-stage mycosis fungoides in palmoplantar localization with large-cell transformation and partial CD30 expression shows complete response to brentuximab vedotin
Anh Khoa Pham, Joi B Carter, Nora R Ratcliffe, et al.
Journal of the American Academy of Dermatology
|
March 5, 2013
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma
Jennifer A DeSimone, Emmanuella Guenova, Joi B Carter, et al.
Oncology (Williston Park, N.Y.)
|
November 13, 2001
Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma
V J Picozzi, B L Pohlman, V A Morrison, et al.
Cell Reports
|
May 25, 2022
Mitochondrial damage-associated molecular patterns trigger arginase-dependent lymphocyte immunoregulation
Lauren P Westhaver, Sarah Nersesian, Adam Nelson, et al.
Nature
|
April 12, 1990
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein
D B Carter, M R Deibel, C J Dunn, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2002
Development of a presynaptic 5-HT1A antagonist
Ronald J Mattson, John D Catt, Charles P Sloan, et al.
Molecular Biology of the Cell
|
November 8, 2014
FRET detection of lymphocyte function-associated antigen-1 conformational extension
Alexandre Chigaev, Yelena Smagley, Mark K Haynes, et al.
Health Services Research
|
February 1, 1986
The Veterans Administration Northwest Regional Health Services Research and Development Field Program: organization, activities, and early outcomes
C D Austin, W B Carter, M L Durham, et al.
Prostate Cancer and Prostatic Diseases
|
April 19, 2017
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
J J Tosoian, H D Patel, M Mamawala, et al.
The Lancet. Infectious Diseases
|
June 9, 2023
A partner protection package for HIV cure-related trials involving analytical treatment interruptions
Karine Dubé, Tia Morton, Lawrence Fox, et al.
Page
of 85
Search research articles
Search
Showing results (741-750 of 841) with videos related to
Sort By:
Page
of 85
Journal of Cutaneous Pathology
|
March 8, 2018
Tumor-stage mycosis fungoides in palmoplantar localization with large-cell transformation and partial CD30 expression shows complete response to brentuximab vedotin
Anh Khoa Pham, Joi B Carter, Nora R Ratcliffe, et al.
Journal of the American Academy of Dermatology
|
March 5, 2013
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma
Jennifer A DeSimone, Emmanuella Guenova, Joi B Carter, et al.
Oncology (Williston Park, N.Y.)
|
November 13, 2001
Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma
V J Picozzi, B L Pohlman, V A Morrison, et al.
Cell Reports
|
May 25, 2022
Mitochondrial damage-associated molecular patterns trigger arginase-dependent lymphocyte immunoregulation
Lauren P Westhaver, Sarah Nersesian, Adam Nelson, et al.
Nature
|
April 12, 1990
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein
D B Carter, M R Deibel, C J Dunn, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2002
Development of a presynaptic 5-HT1A antagonist
Ronald J Mattson, John D Catt, Charles P Sloan, et al.
Molecular Biology of the Cell
|
November 8, 2014
FRET detection of lymphocyte function-associated antigen-1 conformational extension
Alexandre Chigaev, Yelena Smagley, Mark K Haynes, et al.
Health Services Research
|
February 1, 1986
The Veterans Administration Northwest Regional Health Services Research and Development Field Program: organization, activities, and early outcomes
C D Austin, W B Carter, M L Durham, et al.
Prostate Cancer and Prostatic Diseases
|
April 19, 2017
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
J J Tosoian, H D Patel, M Mamawala, et al.
The Lancet. Infectious Diseases
|
June 9, 2023
A partner protection package for HIV cure-related trials involving analytical treatment interruptions
Karine Dubé, Tia Morton, Lawrence Fox, et al.
Page
of 85